Supreme Court Shields Monsanto from Roundup Cancer Lawsuits in Landmark Pesticide Ruling

The U.S. Supreme Court delivered a sweeping victory to Monsanto and its parent company Bayer on Thursday, blocking thousands of lawsuits alleging that the popular weed killer Roundup causes cancer. In a 7-2 decision, the Court ruled that federal pesticide law preempts state-level claims that the company failed to warn consumers about the potential dangers of glyphosate, the herbicide's active ingredient.

The case, Monsanto v. Durnell, centered on a fundamental question of regulatory authority: who controls what appears on pesticide labels? Justice Brett Kavanaugh, writing for the majority, held that the Federal Insecticide, Fungicide, and Rodenticide Act—commonly known as FIFRA—expressly preempts state tort claims that would impose labeling requirements "in addition to or different from" those mandated by the Environmental Protection Agency.

"Because Durnell's state tort claim would impose a pesticide labeling requirement 'in addition to or different from' the label required by EPA, FIFRA expressly preempts Durnell's claim," Kavanaugh wrote. The ruling effectively shields Monsanto from liability in tens of thousands of pending cases that have been working through courts across the country.

The plaintiff, Missouri resident John Durnell, had argued that state juries should retain the authority to evaluate whether Monsanto adequately warned consumers about glyphosate's cancer risks. His legal team pointed to ongoing congressional debates about potential legislative protections for pesticide manufacturers as evidence that federal preemption remained unsettled. The majority rejected that argument, establishing a clear federal supremacy over pesticide labeling standards.

During oral arguments in April, Monsanto's attorney, former Solicitor General Paul Clement, emphasized the need for uniform national standards. "You shouldn't let a single Missouri jury second-guess that judgment," he told the justices, referring to EPA's scientific evaluation of glyphosate safety. The current U.S. Solicitor General, John Sauer, sided with Monsanto, reinforcing the government's position that fragmented state standards would undermine regulatory coherence.

Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch. In her dissent, Jackson argued that the majority fundamentally misunderstood FIFRA's requirements and misinterpreted the scope of its preemption clause. "In accepting Monsanto's argument and holding that Durnell's failure-to-warn claim is preempted, the Court misunderstands FIFRA's requirements, misinterprets the scope of FIFRA's preemption, and ultimately leaves Durnell without a remedy for the significant harms he has suffered," she wrote.

Jackson's dissent highlighted a tension that has divided courts and policymakers: whether adding a cancer warning to a pesticide label truly conflicts with federal law, or merely supplements it. The majority's answer—that any state-imposed warning requirement is preempted—resolves that debate decisively in favor of manufacturers.

For the pest control industry, the ruling carries significant implications. Pesticide applicators, distributors, and manufacturers have long operated under a dual regulatory framework, complying with EPA registration requirements while navigating a patchwork of state tort liability. Thursday's decision simplifies that landscape, establishing that EPA's labeling authority is exclusive and comprehensive.

The decision also intersects with broader political currents. President Trump signed an executive order earlier this year promoting domestic production of glyphosate, citing national security concerns about agricultural chemical supply chains. That order created friction with some supporters of the Make America Healthy Again movement, who have pushed for stricter chemical regulations. Scores of protesters appeared before the Supreme Court during oral arguments to support plaintiffs who claimed harm from Roundup and other chemicals.

Bayer, which acquired Monsanto in 2018, has faced mounting legal costs from Roundup litigation. The company has set aside billions of dollars to settle existing claims while maintaining that glyphosate is safe when used as directed. Thursday's ruling significantly narrows the company's future exposure, potentially saving billions in additional liability.

For agricultural producers and pest control professionals in Texas, the decision provides regulatory clarity. The ruling affirms that EPA's scientific assessments govern pesticide labeling, reducing the risk of state-level litigation that could disrupt access to widely used herbicides. As the 2026 growing season progresses, applicators can proceed with established protocols, confident that federal registration provides meaningful legal protection against failure-to-warn claims.